HR

Harinadh Reddy Pamulapati

Director Additional Director DIN 08082998
DIN 08082998 First appointment Aug 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2018
Shareholding value •••• Premium profile

About Harinadh Reddy Pamulapati

Data last updated:

Harinadh Reddy Pamulapati was an Additional Director at Aptus Therapeutics Private Limited (2022–2023) and Director at Yms Laboratories Private Limited (2018–2020). The companies operate in Pharma.

DIN 08082998
Primary Designation Additional Director
Industry Pharma
First Appointment 25 Aug 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aptus Therapeutics Private Limited U24232TG2010PTC071724
Additional Director07 Jul 20222010₹31.8 Lakh (FY 2024)Active
Yms Laboratories Private Limited U24233TG2011PTC073080
Director25 Aug 20182011₹36.29 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aptus Therapeutics Private Limited
Yms Laboratories Private Limited
Premium access

Shareholding and investment profile for Harinadh Reddy Pamulapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harinadh Reddy Pamulapati

Harinadh Reddy Pamulapati was first appointed on 25 Aug 2018 as Director at Yms Laboratories Private Limited. The most recent appointment on record is 07 Jul 2022 at Aptus Therapeutics Private Limited.

Harinadh Reddy Pamulapati held 2 earlier board appointments: Aptus Therapeutics Private Limited (Additional Director, 07 Jul 2022 to 29 Jul 2023); Yms Laboratories Private Limited (Director, 25 Aug 2018 to 30 Jul 2020).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available